94 related articles for article (PubMed ID: 12206933)
1. Two kinds of endometrial neoplasia arising from different origins in the uterine corpus: comparison of p53 expression and sex steroid receptor status.
Koshiyama M; Ueta M
Eur J Obstet Gynecol Reprod Biol; 2002 Sep; 104(2):167-70. PubMed ID: 12206933
[TBL] [Abstract][Full Text] [Related]
2. [Steroid hormonal receptors, heat shock protein and p53 of endometrioid and clear cell cancers in different localization].
Kedzia W; Spaczyński M
Ginekol Pol; 2002 Aug; 73(8):685-90. PubMed ID: 12369295
[TBL] [Abstract][Full Text] [Related]
3. Clear cell adenocarcinoma arising from a giant cystic adenomyosis: a case report with immunohistochemical analysis of laminin-5 gamma2 chain and p53 overexpression.
Ohta Y; Hamatani S; Suzuki T; Ikeda K; Kiyokawa K; Shiokawa A; Kushima M; Ota H
Pathol Res Pract; 2008; 204(9):677-82. PubMed ID: 18467037
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2.
Lai CR; Hsu CY; Chen YJ; Yen MS; Chao KC; Li AF
J Chin Med Assoc; 2013 Nov; 76(11):629-34. PubMed ID: 23962610
[TBL] [Abstract][Full Text] [Related]
5. Tumors of the uterine isthmus: clinicopathologic features and immunohistochemical characterization of p53 expression and hormone receptors.
Jacques SM; Qureshi F; Ramirez NC; Malviya VK; Lawrence WD
Int J Gynecol Pathol; 1997 Jan; 16(1):38-44. PubMed ID: 8986531
[TBL] [Abstract][Full Text] [Related]
6. P53 expression in adenomyosis in endometrial carcinoma patients.
Taskin M; Lallas TA; Shevchuk M; Barber HR
Gynecol Oncol; 1996 Aug; 62(2):241-6. PubMed ID: 8751556
[TBL] [Abstract][Full Text] [Related]
7. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Horiuchi A; Osada R; Nakayama K; Toki T; Nikaido T; Fujii S
Gynecol Oncol; 1998 Aug; 70(2):295-9. PubMed ID: 9740709
[TBL] [Abstract][Full Text] [Related]
8. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status.
Koshiyama M; Konishi I; Wang DP; Mandai M; Komatsu T; Yamamoto S; Nanbu K; Naito MF; Mori T
Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):265-71. PubMed ID: 8236823
[TBL] [Abstract][Full Text] [Related]
10. Multifocal PEComa (PEComatosis) of the female genital tract associated with endometriosis, diffuse adenomyosis, and endometrial atypical hyperplasia.
Froio E; Piana S; Cavazza A; Valli R; Abrate M; Gardini G
Int J Surg Pathol; 2008 Oct; 16(4):443-6. PubMed ID: 18499690
[TBL] [Abstract][Full Text] [Related]
11. Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma.
Kucera E; Hejda V; Dankovcik R; Valha P; Dudas M; Feyereisl J
Eur J Gynaecol Oncol; 2011; 32(2):182-4. PubMed ID: 21614909
[TBL] [Abstract][Full Text] [Related]
12. Patterns of immunohistochemical staining for p53 expression in hyperplastic endometrium and adenocarcinoma.
Terlikowski S; Lenczewski A; Famulski W; Sulkowska M; Dobrzycka B; Stasiuk-Barmuta A; Kulikowski M
Folia Histochem Cytobiol; 2001; 39 Suppl 2():195-6. PubMed ID: 11820604
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
Lin Z; Cho S; Jeong H; Kim H; Kim I
J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693
[TBL] [Abstract][Full Text] [Related]
14. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
Sherman ME; Bur ME; Kurman RJ
Hum Pathol; 1995 Nov; 26(11):1268-74. PubMed ID: 7590703
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic, and physiologic endometria.
Huang SJ; Cheng L; Lewin KJ; Fu YS
Pathol Res Pract; 1991 May; 187(4):487-95. PubMed ID: 1876529
[TBL] [Abstract][Full Text] [Related]
16. Disappearance of steroid hormone dependency during malignant transformation of ovarian clear cell cancer.
Akahane T; Sekizawa A; Okuda T; Kushima M; Saito H; Okai T
Int J Gynecol Pathol; 2005 Oct; 24(4):369-76. PubMed ID: 16175084
[TBL] [Abstract][Full Text] [Related]
17. [Human telomerase P53 estrogen and progesterone receptor expression in endometrial carcinoma].
Dong Y; Li T; Liang Y; Zou WZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 36(1):61-5. PubMed ID: 14970891
[TBL] [Abstract][Full Text] [Related]
18. [Nucleolar organizer region-associated proteins and estrogen receptor of endometrial adenocarcinoma].
Wan ZM
Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):287-8, 315. PubMed ID: 8243149
[TBL] [Abstract][Full Text] [Related]
19. Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium.
Yu CC; Wilkinson N; Brito MJ; Buckley CH; Fox H; Levison DA
Histopathology; 1993 Oct; 23(4):367-71. PubMed ID: 7905459
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Characteristics of Ten Patients with Atypical Glandular Hyperplasia Transformation of Adenomyosis.
Zhu HL; Gao SY; Shen DH; Cui H
Chin Med J (Engl); 2016 Feb; 129(3):364-6. PubMed ID: 26831242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
